Invesco Dynamic Biotechnology & Gen... (PBE)


+0.86 (+1.52%)
Symbol PBE
Price $57.3533
Beta 0.820
Volume Avg. 0.01M
Market Cap 260.957M
Shares () -
52 Week Range 52.47-68.5
1y Target Est -
DCF Unlevered PBE DCF ->
DCF Levered PBE LDCF ->
ROE 9.54% Neutral
ROA 8.27% Neutral
Operating Margin -
Debt / Equity -
P/E 15.20 Strong Buy
P/B 0.92 Buy


Consensus EPS

Upgrades & Downgrades

Latest PBE news

New York Stock Exchange Arca

The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.